MedPath

WavSTAT study.

Conditions
Barrett oesophagusdysplasianeoplasiaadvanced imagingendoscopyBarrett slokdarmdysplasieslokdarmkankergeavanceerde detectieendoscopie
Registration Number
NL-OMON23646
Lead Sponsor
AMC Amsterdam
Brief Summary

/A

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
Not specified
Target Recruitment
170
Inclusion Criteria

1. Age > 18 – 80 years;

2. BO with a minimal circumferential length of 2 cm;

Exclusion Criteria

1. Prior history of surgical or endoscopic treatment for oesophageal neoplasia;

2. Presence of erosive oesophagitis (Los Angeles classification ≥B);

Study & Design

Study Type
Observational non invasive
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Phase 1 will be used to develop a tissue recognition algorithm by correlating the measured fluorescence spectra to the histology of the corresponding tissue.<br><br /><br /><br>In phase 2 the WavSTAT optical biopsy will be validated and assessed for the following outcome parameters:<br /><br>1. Sensitivity and specificity of WavSTAT for the detection of early Barrett neoplasia (HGIN/EC);<br /><br>2. Additional value of WavSTAT to standard inspection with WLE, compared to inspection with WLE alone for the detection of early Barrett neoplasia (HGIN/EC).
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath